Meanwhile, Sidoti downgraded its Co-Diagnostics Inc [CODX] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Sidoti’s analysts, who began to cover the stock in late December with a ‘”a Buy”‘ rating. Maxim Group also remained covering CODX and has decreased its forecast on March 29, 2021 with a “Hold” recommendation from previously “Buy” rating. Maxim Group revised its rating on May 20, 2020. It rated CODX as “a Buy” which previously was an “a Hold”.
Price Performance Review of CODX
On Tuesday, Co-Diagnostics Inc [NASDAQ:CODX] saw its stock jump 6.06% to $0.36. Over the last five days, the stock has gained 3.66%. Co-Diagnostics Inc shares have fallen nearly -51.69% since the year began. Nevertheless, the stocks have fallen -70.54% over the past one year. While a 52-week high of $2.23 was reached on 01/06/25, a 52-week low of $0.28 was recorded on 04/09/25. SMA at 50 days reached $0.3933, while 200 days put it at $0.8755.
Levels Of Support And Resistance For CODX Stock
The 24-hour chart illustrates a support level at 0.2883, which if violated will result in even more drops to 0.2142. On the upside, there is a resistance level at 0.4682. A further resistance level may holdings at 0.5740. The Relative Strength Index (RSI) on the 14-day chart is 48.71, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0073, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 76.54%. Stochastics %K at 19.76% indicates the stock is a buying.
The most recent change occurred on May 18, 2020 when H.C. Wainwright resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $35.
